Among the companies with shares expected to actively trade in
Thursday's session are Wal-Mart Stores Inc. (WMT), Kohl's Corp.
(KSS) and Weyerhaeuser Co. (WY).
Wal-Mart slashed its earnings guidance for the year, as the
retail giant posted yet another decline in quarterly traffic and
flat same-store sales. Shares fell slightly to $74 in premarket
trading.
Kohl's said fiscal second-quarter earnings improved slightly as
lower expenses masked a decline in sales for the department-store
chain. Shares rose 2.5% to $56.50 premarket.
Weyerhaeuser Co. (WY) raised its quarterly dividend 32% and
unveiled a $700 million share-buyback program as the company looks
to continue reaping the benefits from a renewed focus on its core
wood-products business. Shares gained 2.2% to $33.05 premarket.
Red Robin Gourmet Burgers Inc. (RRGB) said second-quarter
earnings fell amid a jump in food-and-beverage costs, while
same-store sales rose 1.2%. Shares sank 21.7% to $50.57
premarket.
Advance Auto Parts Inc. (AAP) said its second-quarter profit
climbed on a 51.5% rise in sales as the auto-parts retailer's top-
and bottom-lines remain bolstered by the acquisition of General
Parts International Inc. Shares advanced 4.5% to $128.50
premarket.
T-Mobile US Inc.'s (TMUS) chief financial officer on Wednesday
called a $15 billion takeover proposal from French wireless company
Iliad SA (ILD.FR, ILIAY) "inadequate," but hinted it may be open to
a higher offer. Shares edged up to $29.27 premarket.
Cisco Systems Inc. (CSCO) on Wednesday said it will cut about
6,000 jobs after reporting a quarter of little sales growth. Shares
dropped slightly to $25.09 premarket.
Noodles & Co. (NDLS) on Wednesday said second-quarter
results were below its expectations and lowered its outlook for the
full year. Shares tumbled 21.1% to $19.90 premarket.
Supernus Pharmaceuticals Inc. (SUPN) said the U.S. Food and Drug
Administration granted fast track designation for the specialty
pharmaceutical company's attention deficit hyperactivity disorder
treatment. Shares were up 4.4% to $9.80 premarket.
Keurig Green Mountain Inc. (GMCR) said it would increase prices
by up to 9% on all portion packs for its popular Keurig brewing
systems, citing risings costs of green coffee and cocoa.
Watchlist:
Allergan Inc. (AGN) has bought global rights to Taris Holdings
LLC's lead program for $67.5 million in cash upfront and about $225
million in commercial milestone payments, the companies said
Wednesday.
Amgen Inc. (AMGN) and its subsidiary Onyx Pharmaceuticals said
on Wednesday their Kyprolis cancer drug failed to meet its primary
endpoint of improving overall survival for patients with relapsed
and advanced refractory multiple myeloma in a late-stage clinical
trial.
NetEase Inc.'s (NTES, K3MD.SG) second-quarter profit rose nearly
10% as the Chinese Internet portal reported sustained revenue
growth from online games and advertising, which benefited from the
FIFA World Cup.
Re/Max Holdings Inc. (RMAX) reported better-than-expected
second-quarter revenue as the brokerage franchiser continued to
expand its pool of agents.
Tekmira Pharmaceuticals Corp. (TKMR) on Wednesday said it is
looking into ways its experimental Ebola treatment might be used to
combat a serious outbreak in West Africa, even if the drug hasn't
been formally cleared by the various regulatory agencies.
Write to Tom Rojas at tom.rojas@wsj.com and Maria Armental at
maria.armental@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires